Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma

Figure 1 Cone-beam computed tomography image confirmed the position of the radiofrequency probe. A-C: Radiofrequency probe inserted at an angle to avoid lung damage.

Figure 2 A 41-year-old male patient re-examined 2 and 4 years after combination therapy. A: Magnetic resonance imaging (MRI) at 2 years; B: MRI at 4 years. Hepatocellular carcinoma lesions showed pyknosis and necrosis.

Figure 3 Kaplan–Meier analysis of overall survival and progression-free survival. Kaplan–Meier survival curves shown for patients with large hepatocellular carcinomas treated with combination therapy. A: 3-year overall survival; B: 3-year progression-free survival. OS: Overall survival; PFS: Progression-free survival.